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Abstract: Two new drimane sesquiterpenoids (1 and 2), as well as five known compounds (3–7), were isolated from the  
basidiomycete Trichaptum biforme. The structures of new compounds were elucidated by extensive spectroscopic methods, and the 
known compounds were identified by comparing their spectroscopic data with those reported in the literature. The cytotoxicities 
results against five human cancer cell lines of compounds 1 and 2 were negligible. 
Keywords: Trichaptum biforme, drimane sesquiterpenoids, cytotoxicity
Introduction 
The Trichaptum biforme is an edible fungus belonging to 
the family Polyporaceae, which is mainly distributed in  
temperate regions and boreal forests zones throughout the 
world.1 This fungus displays diverse pharmacological  
properties, including antimicrobial, antifungal,2 decolorization 
of methylene blue,3 degradation of pitch,4 and delignification 
activities5. However, to date, the secondary metabolites of T. 
biforme have not been investigated further.2 As a part of our 
search for diverse secondary metabolites from higher fungi,6–11 
we conducted chemical investigations on cultures of T. biforme,
which led to the isolation of two new drimane sesquiterpenoids,
11,12-epoxy-3α,6β,9α,11α-tetrahydroxydrimene (1) and 
11,12-epoxy-3α,9α,11α-trihydroxydrimene (2), together with 
four known analogues, danilol (3),12 isodrimeninol (4),13,14 
3β,11,12-trihydroxydrimene (5),15,16 and 11,12-dihydroxy-
drimene (6),16,17 as well as one chain-shaped sesquiterpenoid, 
2,10-dodecadiene-1,6,7-triol (7).18 Herein, we report the  
isolation and structural elucidation of 1 and 2. All of these 
compounds were tested for their cytotoxicities against five 
human cancer cell lines. 
 
Results and Discussion 
Compound 1 was obtained as white powder. Its molecular 
formula C15H24O5 was deduced by the HRESIMS at m/z 
307.1522 [M + Na]+ (calcd 307.1521 for C15H24O5Na),  
indicating four degrees of unsaturation. The IR spectrum 
showed absorption bands for hydroxy groups (3423 cm–1) and 
C=C double bonds (1632 cm–1). The 13C NMR spectrum  
revealed 15 carbon signals for three methyls, three methylenes 
(one oxygenated), five methines (one olefinic and three  
oxygenated), and four quaternary carbons (one olefinic and 
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one oxygenated) (Table 1). Consideration of the above data 
led to the conclusion that 1 possessed three rings and four OH 
groups. The 1H-1H COSY spectrum revealed the presence of 
the two partial structures as shown in Figure 1. The HMBC 
spectrum (Figure 1) of 1 showed correlations from both δH 
1.36 (3H, s, Me-13) and 1.15 (3H, s, Me-14) to δC 78.7 (d, C-
3), 39.3 (s, C-4), and 41.4 (d, C-5), and from δH 3.33 (1H, br. s, 
H-3) to C-5, indicated that C-3 and C-5 were attached to the 
quaternary carbon C-4. Furthermore, the HMBC correlations 
(Figure 1) from δH 2.43 (1H, m, H-1a) to δC 78.5 (s, C-9), 38.8 
(s, C-10), and 19.4 (q, C-15), and from δH 2.30 (1H, d, H-5) to 
C-9, C-10, C-1, and C-15, revealed that C-1 and C-9 were 
attached to the quaternary carbon C-10 and the connectivity 
from C-5 to C-10. In addition, the HMBC correlations (Figure 
1) from δH 4.19 (1H, dt, H-12b) to C-7, C-11, and C-9  
revealed the connectivity of C-12 to C-8 and C-11 to C-12 via 
an oxygen atom, which formed a five-membered ring. The 
data described above gave a gross structure of 1 belonging to a 
drimane sesquiterpenoid, which was related to that of danilol 
(3),8 except for two more hydroxy groups at C-6 and C-9 in 1. 
The relative configuration of 1 was deduced from the ROESY 
spectrum (Figure 1). Biogenetically, the methyl group of Me-
15 was β-oriented, whilst H-5 was α-oriented.8 Therefore, the 
key ROESY correlation between Me-15 and H-11 allowed H-
11 to be β-oriented, while the ROESY correlation of H-5/H-6 
indicated that H-6 was β-oriented, Moreover, a 3D structure 
model of the ROESY correlation of Me-15/H-11 was  
determined and it was revealed that the OH-9 could only be α-
oriented (Figure 1). The broad peak of H-3 indicated that the 
OH-3 was α-oriented. Therefore, compound 1 was elucidated 
as 11,12-epoxy-3α,6β,9,11α-tetrahydroxydrimene. 
Compound 2 was deduced as the molecular formula 
C15H24O4 by the HRESIMS at m/z 291.1567 [M + Na]+ (calcd 
291.1572 for C15H24O4Na). With the assistance of 2D (1H-1H 
COSY, HSQC, HMBC) NMR data, compound 2 was shown to 
possess the same tricyclic carbon skeleton as that of 1.  
Furthermore, a comparison of the 13C NMR data with those of 
1 (Tables 1) showed that they were similar, except for the  
absence of a hydroxy group at C-6 in 2. This assignment was 
confirmed by 1H-1H COSY correlations of δH 2.04 (1H, m, H-
6a) and 1.99 (1H, m, H-6b) with δH 5.68 (1H, m, H-7) and 
HMBC correlations from H-6 to δC 122.9 (d, C-7) and 139.0 (s, 
C-8). The broad peak of H-3 (δH 3.38, 1H, br. s) indicated that 
OH-3 was α-oriented. The ROESY correlations of Me-15/H-
11 indicated that the relative configuration at C-9 and C-11 in 
2 was the same as that of 1. Thus, compound 2 was elucidated 
as 11,12-epoxy-3α,9,11α-trihydroxydrimene. 
Compounds 1 and 2 were evaluated for their cytotoxicities 
against five human cancer cell lines namely: SK-BR-3 breast, 
SMMC-7721 hepatocellular carcinoma, HL-60 myeloid  
leukemia, PANC-1 pancreatic cancer, and A-549 lung cancer 
cell lines, using the MTT method as reported previously.19 
Unfortunately, nither compound 1 or 2 displayed any  
cytotocicity activity againist these cancer cell lines (IC50 > 40 μM). 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured on a Horiba SEPA-300 polarimeter. IR spectra were 
obtained on a Bruker Tensor 27 spectrometer with KBr pellets. 
1D and 2D NMR experiments were performed on a Bruker 
AM-400, DRX-500 or AVANCE III-600 spectrometer with 
TMS as the internal standard. Chemical shifts (δ) were  
expressed in ppm with reference to the solvent signals. Mass 
spectra (MS) were recorded on a VG Auto Spec-3000 or an 
 
Figure 1.  Key 2D NMR correlations of 1 
Table 1. 1H (400 MHz) and 13C (100 MHz) NMR data of 1 and 2 in methanol-d4 
 
no. 
1  2 
δH δC δH δC 
1 2.43, m, Ha; 1.00, m, Hb 25.9, t  2.31, m, Ha; 1.00, m, Hb 25.1, t 
2 2.04, m, Ha; 1.59, m, Hb 25.2, t 1.92, m, Ha; 1.59, m, Hb 25.7, t 
3 3.33, br. s  78.7, d 3.38, br. s 76.7, d 
4  39.3, s  38.9, s 
5 2.30, d (5.0) 41.4, d 2.31, overlap 37.6, d 
6 4.40, m 66.4, d 2.04, m, Ha,; 1.99, m, Hb 24.8, t 
7 5.67, m 124.8, d 5.68, m 122.9, d 
8  140.1, s  139.0, s 
9  78.5, s  78.5, s 
10  38.8, s  38.2, s 
11 5.34, s 99.3, d 5.26, s 99.1, d 
12 4.56, dt (12.4, 2.4, Ha); 4.19, dt (12.4, 1.4, Hb) 67.9, t 4.50, ddd (11.7, 5.3, 3.0, Ha); 4.08, ddd (11.7, 3.5, 1.9, Hb) 68.2, t 
13 1.36, s 25.6, q 0.97, s 22.9, q 
14 1.15, s 28.4, q 0.96, s 29.1, q 
15 1.18, s 19.4, q  0.90, s 16.5, q 
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APIQSTAR time-of-flight spectrometer. Column chromatog-
raphy (CC) was performed using a silica gel (200–300 mesh; 
Qingdao Marine Chemical Co., Ltd., China), and Sephadex 
LH-20 (Amersham Biosciences, Sweden). Fractions were 
monitored for qualitative analysis using TLC (GF254, Qingdao 
Marine Chemical Co., Ltd., China), and spots were visualized 
by spraying with 10% H2SO4 in ethanol. 
 
Fungal Material and Cultivation Condition. T. biforme 
was isolated from a tissue culture of its fruiting bodies, which 
was originally collected from Changbai Mountain in Jilin 
Province, China in 2009. The specimen was authenticated by 
Prof. Tuli Guer from Jilin Agricultural University. A voucher 
specimen was deposited in the Herbarium of Kunming Institute
of Botany, Chinese Academy of Sciences. The culture medium 
consisted of glucose 5%, peptone 0.15%, yeast powder 0.5%, 
KH2PO4 0.05% and MgSO4 0.05%. Fermentation was  
conducted using a shaker at 24 °C and 150 rpm for 26 days. 
 
Extraction and Isolation. The culture broth of T. biforme 
(20 L) was filtered, and the filtrate was extracted three times 
with EtOAc. The organic layer was concentrated under  
reduced pressure to give an oily residue (3.9 g) that was  
subjected to column chromatography (CC) over silica gel 
(200–300 mesh) eluting with CHCl3/MeOH (from 100:0 to 
0:100) to derive fractions A–G. Fraction A (130 mg) was  
isolated by repeated CC on silica gel (petroleum ether-Me2CO) 
to give compounds 4 (2.3 mg), 5 (1.2 mg) and 6 (1.9 mg). 
Fraction C (88 mg) was subjected to Sephadex LH-20 CC 
(Me2CO) and purified by repeated CC on silica gel (petroleum 
ether-Me2CO) to derive compounds 3 (2.5 mg) and 7 (3.7 mg). 
Fraction E (600 mg) was subjected to Sephadex LH-20 CC 
(CHCl3-MeOH, 1:1) and purified by column chromatography 
on silica gel eluted with petroleum ether-acetone (3:1) to  
derive compound 2 (45.8 mg). Fraction G (200 mg) was  
isolated first by CC on silica gel eluted with petroleum ether-
EtOAc (1:4) and purified by Sephadex LH-20 (CHCl3-MeOH, 
1:1) to afford compound 1 (21.3 mg). 
 
11,12-Epoxy-3α,6β,9α,11α-tetrahydroxydrimene (1): 
colorless oil; [α]25D   – 163.0 (c 0.36, CHCl3); 1H NMR (metha-
nol-d4, 400 MHz) and 13C NMR (methanol-d4, 100 MHz) data, 
see Table 1; IR (KBr) νmax: 3423, 2924, 2872, 1632, 1385, 
1151, 1047, 1026, 911 cm–1; ESIMS (pos.) m/z 307 ([M + Na]+, 
100); ESIHRMS m/z 307.1522 (calcd for C15H24O5Na, 
307.1521). 
 
11,12-Epoxy-3α,9α,11α-trihydroxydrimene (2): colorless 
oil; [α]26D   – 95.9 (c 0.65, CHCl3); 1H NMR (methanol-d4, 400 
MHz) and 13C NMR (methanol-d4, 100 MHz) data, see Table 1; 
IR (KBr) νmax 3483, 3361, 3280, 2971, 2925, 2878, 1630, 1434, 
1389, 1125, 1101, 1056, 1041, 999, 907 cm–1; ESIMS (pos.) 
m/z 291 ([M + Na]+, 100); ESIHRMS m/z 291.1567 (calcd for 
C15H24O4Na 291.1572). 
 
Cytotoxicity Assay. Five human cancer cell lines: SK-BR-3 
breast, SMMC-7721 hepatocellular carcinoma, HL-60 myeloid 
leukemia, PANC-1 pancreatic cancer and A-549 lung cancer. 
All the cells were cultured in RPMI-1640 or DMEM medium 
(Hyclone, USA), supplemented with 10% fetal bovine serum 
(Hyclone, USA) in 5% CO2 at 37 C. The cytotoxicity assay 
was performed according to the MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide) method in 96-well 
microplates. Briefly, 100 µL adherent cells were seeded into 
each well of 96-well cell culture plates and allowed to adhere 
for 12 h before isolated compound addition. The suspended 
cells were seeded just before the isolated compounds were 
added with an initial density of 1 × 105 cells/mL. Each tumor 
cell line was exposed to the test compound at concentrations of 
0.0625, 0.32, 1.6, 8, and 40 μM in triplicates for 48 h, with 
cisplatin (sigma, USA) as a positive control. After the  
compound treatment, cell viability were detected and cell 
growth curve was graphed. 
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